China's Increasing Export Orientation

28 July 1996

Zheng Xiaoyu, director-general of China's State Administration of Medicines, has said that China's pharmaceutical industry is increasingly opening up to the outside world, particularly in terms of its exports, reports China Foreign Trade. At end-1995, China's drug industry had 1,500 foreign-funded joint ventures, with foreign funding in the sector exceeding $2.5 billion.

15 of the world's top 20 drug companies have a presence in China, while the sales value of foreign-funded pharmaceutical joint ventures accounted for 13% of the total Chinese drug industry last year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight